Physician profile
David Bui
NPI 1104977636
$2,525.89
in general payments reported to CMS, 2019-2025
19 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $566 · 2020: $210 · 2021: $118 · 2022: $502 · 2023: $371 · 2024: $318 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,129.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,129.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $481.85 | 2019-2025 | Cequa |
| Oyster Point Pharma, INC. | $442.29 | 2022-2025 | Tyrvaya, Ryzumvi |
| Alcon Vision LLC | $419.77 | 2019-2025 | Hydrus Microstent, Eysuvis, Rocklatan |
| Aerie Pharmaceuticals, INC. | $227.73 | 2019-2020 | |
| Biotissue Holdings INC. | $142.29 | 2019-2022 | |
| Allergan, INC. | $125.17 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $111.46 | 2024-2025 | Xdemvy |
| Kala Pharmaceuticals, INC. | $82.08 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $67.48 | 2019-2023 | |
| Thea Pharma INC. | $65.98 | 2024-2025 | Iyuzeh |
| Harrow Eye, LLC | $64.48 | 2025 | Vevye |
| Horizon Therapeutics Plc | $61.50 | 2021-2022 | |
| Abbvie INC. | $50.83 | 2025 | |
| Glaukos Corporation | $47.83 | 2022-2023 | |
| Sight Sciences, INC. | $40.82 | 2020-2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ivantis, INC | $34.42 | 2020 | |
| Dompe US, INC. | $27.98 | 2024 | Oxervate |
| Eyevance Pharmaceuticals LLC | $19.34 | 2019 | |
| Merz North America, INC. | $12.59 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Bui listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.